Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community

22 June 2018

Medicines for Europe is committed to bringing accessible, high quality […]

Read more

Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest

14 June 2018

The joint 24th Medicines for Europe and 21st IGBA Annual […]

Read more

SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference

25 April 2018

Key authorities, lawyers and industry leaders discussed today in London […]

Read more

Joint Declaration on Pharmaceuticals in the Environment

10 April 2018

We, the signatories of this declaration, recognise and understand the […]

Read more

Statement in response to the EU Council ratifying the Brexit transition deal

23 March 2018

Today’s agreement on a transition period is welcome news for […]

Read more

European health community issues key questions Article 50 negotiations must answer for patients and public health

8 March 2018

The European Health Community has warned that time is running […]

Read more

Supply chain commitment to tackling problem of medicine shortages

2 March 2018

Open

IGBA congratulates the Australian government for maintaining their biologics naming convention and for strengthening pharmacovigilance

29 January 2018

Open

2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems

25 January 2018

This week in London, Medicines for Europe gathers regulators and […]

Read more

Vigilance saves lives! More focus needed on sustainability and patient engagement

24 January 2018

National authorities, regulators, industry leaders and key stakeholders gathered in […]

Read more

Subscribe to our newsletter